The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation by Xin Xie, Hai-Lian Bi,

Slides:

Advertisements

Similar presentations

Journal of Molecular and Cellular Cardiology

Advertisements

Cardiac-Specific Overexpression of HIF-1α Prevents Deterioration of Glycolytic Pathway and Cardiac Remodeling in Streptozotocin-Induced Diabetic Mice

Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway SuppressionCLINICAL PERSPECTIVE by Daile.

Dapper-1 Induces Myocardial Remodeling Through Activation of Canonical Wnt Signaling in CardiomyocytesNovelty and Significance by Marco Hagenmueller, Johannes.

The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214

Volume 137, Issue 4, Pages (October 2009)

Volume 15, Issue 22, Pages (November 2005)

Wenqi Wang, Nan Li, Xu Li, My Kim Tran, Xin Han, Junjie Chen

FIP200 maintains microRNA1198-5p expression via Ago2 in naïve T cells.

TET3 Inhibits Type I IFN Production Independent of DNA Demethylation

Volume 137, Issue 4, Pages (October 2009)

Volume 21, Issue 6, Pages (November 2017)

Volume 25, Issue 1, Pages (January 2017)

Volume 125, Issue 4, Pages (May 2006)

USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1

Fig. 6 CCR7 neutralizing antibody inhibited CCR7+cell expansion in the kidney, RDLN, and spleen and attenuated renal inflammation and fibrosis. CCR7 neutralizing.

Fig. 3 E2F1 interacts with components of the splicing machinery.

Biological consequence of SENP7 alternative splicing for E2F1 activity

Adipose tissue dysfunction induces increased liver HIF-1α expression

The wild-type BRCA1-BARD1 EM structure resembles a clamp-like motif

Fig. 3 Biological function of TG2 and the interaction with MT-2.

Fig. 5 GP38 localization to the viral envelope and plasma membrane.

Fig. 1 Neu1−/− fibroblasts have characteristics of myofibroblasts.

Fig. 2 TGF-β1 signaling drives fibrosis in Neu1−/− muscle, which is rescued by AAV-mediated gene therapy. TGF-β1 signaling drives fibrosis in Neu1−/− muscle,

Fig. 2 Contribution of SQSTM1 to the autophagic degradation of ARNTL.

Fig. 1 Genes up-regulated in Zic5 KO cells correlate with the increased glycolytic state. Genes up-regulated in Zic5 KO cells correlate with the increased.

Fig. 6 RUNX/CBFB interaction inhibitor, Ro5-3335, significantly decreases mouse neurofibroma growth in vivo. RUNX/CBFB interaction inhibitor, Ro5-3335,

Fig. 3 Photon number statistics resulting from Fock state |l, S − l〉 interference. Photon number statistics resulting from Fock state |l, S − l〉 interference.

Fig. 4 Cdc42 enhances the cellular uptake of EVs.

Fig. 5 Simultaneous absence of caspase-3 and -7 is required for significant decrease of caspase-8 and -9 activation in intrinsic apoptosis. Simultaneous.

Fig. 4 Activation of mitochondrial apoptosis pathway by n-HA.

Fig. 4 NDR2 interacts with RIG-I and promotes RIG-I K63-linked polyubiquitination. NDR2 interacts with RIG-I and promotes RIG-I K63-linked polyubiquitination.

Fig. 5 NDR2 enhances TRIM25-mediated RIG-I K63-linked ubiquitination via facilitating recruitment of TRIM25 to RIG-I. NDR2 enhances TRIM25-mediated RIG-I.

Fig. 3 Hydrostatic pressure induces intracellular calcium increase via TRPM7 activation. Hydrostatic pressure induces intracellular calcium increase via.

Fig. 1 IDH3α expression is elevated in human-derived gliomas.

Structural analysis of BRCA1 reveals modification hotspot

A Direct HDAC4-MAP Kinase Crosstalk Activates Muscle Atrophy Program

Fig. 1. Matrix stiffness sensitizes myofibroblasts to apoptosis induced by inhibition of their mechanotransduction pathways. Matrix stiffness sensitizes.

Fig. 2 Regulation of CD73 and CD39 cell membrane expressions and extracellular adenosine levels by ERs in osteoprogenitor cells. Regulation of CD73 and.

IDH3α interacts with cSHMT during S phase at the nuclear lamina

Fig. 3 Regulation of CD73 and CD39 cell membrane expression and extracellular adenosine levels by ERs in osteoclasts. Regulation of CD73 and CD39 cell.

Fig. 1 Exon 44–deleted DMD patient iPSC-derived cardiomyocytes express dystrophin after CRISPR-Cas9–mediated genome editing. Exon 44–deleted DMD patient.

Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations by Jaesung P. Choi, Rui Wang,

Fig. 2 IRF8 is expressed in CD68+ macrophages after SCI.

Fig. 2 Viperin promotes methionine oxidation of KSHV helicase.

Fig. 4 Adenosine A2BR signaling promote osteogenic and inhibit osteoclast differentiation in vitro. Adenosine A2BR signaling promote osteogenic and inhibit.

SIRT7-mediated ATM deacetylation is essential for its deactivation and DNA damage repair by Ming Tang, Zhiming Li, Chaohua Zhang, Xiaopeng Lu, Bo Tu, Ziyang.

Fig. 3 DUB proteins act at different levels of type I IFN pathways.

Microfluidic platform for cell phenotype and gene function analysis

c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1

Fig. 5 C9orf72 knockdown disrupts autophagy induction.

Fig. 6 MSC encapsulation in vitro within PdBT cross-linked gels.

Fig. 6 The C9ORF72/SMCR8 complex regulates ULK1.

Fig. 6 The combined therapeutic efficacy of N-pepABS and low dose of Dox on MDA-MB-231 xenografts. The combined therapeutic efficacy of N-pepABS and low.

Fig. 3 Effects of ASO and eGLP1-ASO conjugates on gene expression and protein levels in vitro in cell lines and primary mouse islet cells. Effects of ASO.

Fig. 2 ITGA5 knockdown attenuates hPSC activation, differentiation, and functions. ITGA5 knockdown attenuates hPSC activation, differentiation, and functions.

Fig. 2 Supraballs and films from binary SPs.

Fig. 1 Schematic structure of a fluorescently labeled eGLP1-conjugated MALAT1 ASO and internalization of fluorescent eGLP1 and eGLP1-MALAT1-ASO. Schematic.

Fig. 3 MCA-mediated neutrophil recruitment accelerates bacterial clearance in the skin. MCA-mediated neutrophil recruitment accelerates bacterial clearance.

Fig. 6 Methionine oxidation catalyzed by viperin increases the stability and function of RNA helicase RIG-I. Methionine oxidation catalyzed by viperin.

Fig. 4 Systemic AAV9 delivery of gene editing components to ΔEx44 mice rescues dystrophin expression. Systemic AAV9 delivery of gene editing components.

by Omesha N. Perera, Alexander P. Sobinoff, Erdahl T

Fig. 1 Cellular PFAS negatively regulates RTA-dependent transcriptional activation. Cellular PFAS negatively regulates RTA-dependent transcriptional activation.

Fig. 2 hTERT induces expression of heat shock protein genes through HSF1 and interacts with Hsp70-1. hTERT induces expression of heat shock protein genes.

Fig. 5 Treatment with molecules 13, 14, and 15 decreases HIV-1 R5 infection in human macrophages. Treatment with molecules 13, 14, and 15 decreases HIV-1.

Fig. 5 hTERT promotion of Hsp70-1 telomere localization is dependent on Apollo and assists the telomere protective function of Apollo. hTERT promotion.

Fig. 3 Correction of Dmd exon 44 deletion in mice by intramuscular AAV9 delivery of gene editing components. Correction of Dmd exon 44 deletion in mice.

Fig. 4 MxB intermolecular assembly interfaces and their role in the MxB assembly and HIV-1 inhibition. MxB intermolecular assembly interfaces and their.

Mitochondrial import of CerS1 from smooth ER mediates lethal mitophagy

Cxxc1-deficient TH17 cells exhibit a Treg cell–like expression profile

Presentation transcript:

The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation by Xin Xie, Hai-Lian Bi, Song Lai, Yun-Long Zhang, Nan Li, Hua-Jun Cao, Ling Han, Hong-Xia Wang, and Hui-Hua Li Science Volume 5(5):eaau0495 May 8, 2019 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 1 β5i is increased in hypertrophic hearts and HF patients. β5i is increased in hypertrophic hearts and HF patients. (A) Cluster of the proteasome gene expression profiles in saline- or Ang II–infused mouse heart at day 1 (n = 3 samples per group). (B) qPCR analyses of β1, β2, β5, β1i, β2i, and β5i mRNA expression in saline- or Ang II–infused mouse heart at day 1 and control (n = 3 per group). (C) Protein levels of β5i in NRCMs exposed to Ang II (100 nM) at different time points (top) and quantification (bottom, n = 3). (D and E) Protein levels of β5i in WT hearts after 2 or 4 weeks of Ang II infusion (1000 ng/kg per min) or TAC operation (top) and quantification (bottom, n = 3). (F) Neonatal rat fibroblasts were treated with Ang II for 0 to 24 hours. The β5i protein expression was examined by Western blot analysis (top) and quantification of the relative protein levels (bottom, n = 3). (G) Representative immunohistochemical staining of β5i and BNP proteins in the heart tissues from normal control and HF patients (left). Quantification of β5i- and BNP-positive areas (right, n = 3). (H and I) β5i level and chymotrypsin-like activity in blood samples of normal controls (n = 38) and HF patients (n = 38). Data are presented as means ± SEM, and n represents the number of samples per group. *P < 0.05 and **P < 0.01 versus saline, sham, or normal control. RLU, relative luciferase units. Xin Xie et al. Sci Adv 2019;5:eaau0495 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 2 Knockdown of β5i inhibits cardiomyocyte hypertrophy and activates autophagy. Knockdown of β5i inhibits cardiomyocyte hypertrophy and activates autophagy. (A) Representative images of double immunostaining [green for α-actinin and blue for 4′,6-diamidino-2-phenylindole (DAPI)] of NRCMs transfected with Ad-siRNA-β5i or siRNA-control after Ang II stimulation. Quantification of cell surface area (at least 150 cells counted per experiment; right). (B) qPCR analyses of ANF and BNP mRNA expression (right, n = 5). (C) Immunostaining of cardiomyocyte size with α-actinin (red) and DAPI (blue) infected with Ad-GFP or Ad-β5i after Ang II stimulation. Quantification of cell surface area (at least 150 cells counted per experiment; right). (D) qPCR analyses of ANF and BNP mRNA expression (right, n = 5). (E) Protein levels of β5i, p-AKT, AKT, p-ERK1/2, and ERK1/2 in NRCMs treated as in (A) and quantification (n = 3). (F) Protein levels of β5i, LC3, ATG5, ATG6, ATG7, ATG12, p62, and p53 in NRCMs infected with scrambled siRNA-control or siRNA-β5i after Ang II treatment (top) and quantification (bottom, n = 3). (G) Protein levels of β5i, LC3, ATG5, ATG6, ATG7, ATG12, p62, and p53 in NRCMs infected with Ad-GFP control or Ad-β5i after Ang II treatment (top) and quantification (bottom, n = 3). (H) qPCR analysis of autophagy-related genes ATG5, ATG7, and ATG6 (Beclin-1) and mRNA levels in primary cardiomyocytes infected with siRNA-control or siRNA-β5i after Ang II treatment (n = 3). Data are presented as means ± SEM, and n represents the number of samples. For (A), (B), (E), and (F), *P < 0.05 and **P < 0.01 versus siRNA-control + saline; #P < 0.05 and ##P < 0.01 versus siRNA-control + Ang II. For (C), (D), and (G), *P < 0.05 and **P < 0.01 versus Ad-GFP + saline; #P < 0.05 versus Ad-GFP + Ang II. Xin Xie et al. Sci Adv 2019;5:eaau0495 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 3 β5i interacts with ATG5 and promotes its degradation. β5i interacts with ATG5 and promotes its degradation. (A) Endogenous protein interactions were examined in cardiomyocyte lysates immunoprecipitated (IP) with rabbit IgG or anti-β5i antibody and analyzed by Western blot (WB) with antibody to detect ATG5 and β5i. (B) HEK293 cells were transfected with the indicated plasmids. Equal amounts of protein lysates were immunoprecipitated with anti-Myc antibody and analyzed by WB with the indicated antibodies. (C) Domains of β5i involved in binding to ATG5. WT β5i and β5i truncations expressed in HEK293 cells were mapped with Flag-GFP tagged. Flag-GFP–tagged β5i proteins were precipitated with anti-Myc antibody and analyzed by SDS–polyacrylamide gel electrophoresis (SDS-PAGE) with antibodies against Flag and Myc. aa, amino acids. (D) Interaction domains of ATG5 required for binding to β5i were mapped by coimmunoprecipitation. HEK293 cells were transfected with Flag-GFP-β5i and Myc-ATG5 (full-length and truncations) plasmids. Equal amounts of lysates were prepared for immunoprecipitation with a Myc antibody and immunoblotted with antibodies for Myc or Flag. (E) Deletion constructs of β5i in (C) that bind to ATG5. (F) Deletion constructs of ATG5 in (E) that bind to β5i. (G and H) Lysates from NRCMs infected with siRNA-control, siRNA-β5i, Ad-GFP, or Ad-β5i were immunoprecipitated with anti-ATG5 antibody. Western blot analysis of ubiquitin-conjugated ATG5 with anti-ubiquitin (Ub) and anti-ATG5 (top, n = 3). Input showed the expression of the corresponding proteins in whole-cell lysates (bottom). Quantification of ubiquitinated ATG5 (right). (I and J) NRCMs were infected with siRNA-control, siRNA-β5i, Ad-GFP, or Ad-β5i and then treated with cycloheximide (CHX; 10 μM) for the indicated time periods. Representative Western blot analysis of β5i and ATG5 protein levels for each group (left) and quantification of ATG5 level (right, n = 3). GAPDH as an internal control. *P < 0.05 and ***P < 0.001 versus siRNA-control or Ad-GFP. Xin Xie et al. Sci Adv 2019;5:eaau0495 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 4 KO of β5i suppresses cardiomyocyte size through autophagy. KO of β5i suppresses cardiomyocyte size through autophagy. (A) NRCMs were infected with siRNA-control or siRNA-β5i and then treated with Ang II for 24 hours. Representative images of double immunostaining (red: α-actinin for cardiomyocytes; blue: DAPI for nuclei) for measurement of cell size. Quantification of myocyte surface area (right, 150 cells counted per experiment, n = 3). Scale bar, 50 μm. (B) qPCR analysis of ANF mRNA expression in NRCMs treated as in (A) (n = 3). (C) Protein levels of β5i, ATG5, p-AKT, AKT, p-ERK1/2, and ERK1/2 in NRCMs transfected with siRNA-control, siRNA-β5i, or siRNA-ATG5 after 24 hours of saline or Ang II stimulation and quantification of each protein level (n = 3). (D) NRCMs were infected with siRNA-control or Ad-siRNA-β5i and then treated with chloroquine (CQ) (5 μM) and Ang II for 24 hours. Representative images of double immunostaining for measurement of cardiomyocyte size (left). Quantification of cell surface area (150 cells counted per experiment, n = 3). Scale bar, 50 μm. (E) qPCR analysis of ANF mRNA expression in NRCMs treated as in (D) (n = 5). (F) Protein levels of β5i, ATG5, p-AKT, AKT, p-ERK1/2, and ERK1/2 in NRCMs treated as in (D) and quantification of each protein level (n = 3). GAPDH as an internal control. Data are presented as means ± SEM. *P < 0.05 versus siRNA-control + Ang II; #P < 0.05 and ##P < 0.01 versus siRNA-β5i + Ang II. Xin Xie et al. Sci Adv 2019;5:eaau0495 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 5 Deficiency of β5i attenuates pressure overload–induced cardiac hypertrophy in mice. Deficiency of β5i attenuates pressure overload–induced cardiac hypertrophy in mice. WT and β5i KO mice were subjected to sham or TAC operation for 6 weeks. (A) Representative M-mode echocardiography of the left ventricle (top). Measurement of ejection fraction (EF%) and fractional shortening (FS%) (bottom, n = 7). (B) Representative images of heart size photographed with a stereomicroscope (top) and HW/BW and HW/TL ratios (bottom, n = 7). (C) Cardiac myocyte size and fibrosis were detected by tetramethyl rhodamine isothiocyanate (TRITC)–labeled wheat germ agglutinin (WGA) staining and Masson’s trichrome staining, respectively. Scale bar, 50 μm. (D) Quantification of the relative myocyte cross-sectional area (200 cells counted per heart) and fibrosis (n = 5). (E) Protein levels of β5i, ATG5, LC3, p-AKT, AKT, p-ERK1/2, and ERK1/2 in the heart tissues and quantification (n = 5). GAPDH as an internal control. (F) Lysates from heart tissues of WT β5i KO mice after 6 weeks of sham or TAC were immunoprecipitated with anti-ATG5 antibody. Western blot analysis of ATG5 ubiquitination with anti-ubiquitin or ATG5 antibody (left). Quantification of the relative ubiquitinated ATG5 level (middle, n = 3) and input (Western blot analysis of each protein with corresponding antibody) (right). β-Actin as an internal control. Data are presented as means ± SEM, and n represents the number of animals per group. *P < 0.05 and **P < 0.01 versus WT + sham; ##P < 0.01 versus WT + TAC. Xin Xie et al. Sci Adv 2019;5:eaau0495 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 6 Cardiac-specific overexpression of β5i aggravates pressure overload–induced cardiac hypertrophy. Cardiac-specific overexpression of β5i aggravates pressure overload–induced cardiac hypertrophy. WT and β5i-Tg mice were subjected to sham or TAC operation for 3 weeks. (A) Representative M-mode echocardiography of the left ventricle (top). Measurement of EF% and FS% (bottom, n = 5). (B) Hematoxylin and eosin staining of heart sections and HW/BW and HW/TL ratios (bottom, n = 5). (C) Cardiac myocyte size and fibrosis were detected by FITC-labeled WGA staining (top) and Masson’s trichrome staining (bottom). Scale bar, 100 μm. (D) Quantification of the relative myocyte cross-sectional area (200 cells counted per heart, left) and fibrotic area (right, n = 5). (E) Protein levels of β5i, ATG5, LC3, p-AKT, AKT, p-ERK1/2, and ERK1/2 in the heart tissues (left) and quantification (right, n = 5). (F) Lysates from WT and β5i-Tg mice heart after 3 weeks of sham or TAC were immunoprecipitated with anti-ATG5 antibody. Western blot analysis of ubiquitin-conjugated ATG5 (left). Quantification of the relative ubiquitinated ATG5 level (middle, n = 3) and input of each protein (right). Data are presented as means ± SEM, and n represents the number of animals per group. *P < 0.05 and **P < 0.01 versus WT + sham; #P < 0.05 and ##P < 0.01 versus WT + TAC. Xin Xie et al. Sci Adv 2019;5:eaau0495 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).